Expression of the cell-surface protein CD47 allows some normal cells to avoid phagocytosis by macrophages. In this issue, Jaiswal et al. (2009) and Majeti et al. (2009) show that elevated CD47 expression by leukemic stem cells inhibits macrophage activity and is an indicator of poor prognosis for patients with acute myeloid leukemia.
the quantitative scoring method, and the biological replicates that were performed. The current sensitivity of mass spectrometry, combined with available protein databases, makes protein identification accurate and efficient such that even weaker interactions can be identified. The approach taken by Sowa et al. to find high-confidence interaction proteins of DUBs from mass spectrometry data is systematic and unbiased. Thus, it is highly valuable to those seeking to identify and analyze protein interactions by mass spectrometry. Although such efforts are in many cases accurate in delineating interactions, they remain in great need of a CompPASS to understand where the findings lie on the biological map. The greatest value of the approach taken by Sowa et al. may be in the ability to link a protein of interest to a defined biological pathway, thereby allowing for more focused hypotheses and experiments.
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Cline, M.S., Smoot, M., Cerami, E., Kuchinsky, A., Landys, N., Workman, C., Christmas, R., AvilaCampilo, I., Creech, M., Gross, B., et al. (2007 MicroRNAs (miRNAs) are 21-23 nt RNAs that interact with Argonaute (Ago) proteins to regulate gene expression in plants and animals through cleavage or translational repression of target mRNAs (Carthew and Sontheimer, 2009) . In animals, the processing steps required to transform initial primary miRNA transcripts (pri-miRNAs) to mature miRNAs are carried out by the RNase III enzymes Drosha (assisted by the RNA-binding protein DGCR8/Pasha in a complex known as the Microprocessor) and Dicer (Kim et al., 2009) (Figure 1 ). Although RNA silencing in vertebrates is centered on endogenous RNAs, flies, worms, and plants utilize the small-interfering RNA (siRNA) pathway to fight viral infection by using viral double-stranded RNA as a template for the synthesis of small effector RNAs (Ding and Voinnet, 2007) . Two parallel RNA silencing pathways exist in Drosophila with Dicer-1 and Ago1 supporting the miRNA pathway, and Dicer-2, Ago2, and the RNA-binding protein R2D2 supporting the siRNA pathway ( Figure  1 ) (Carthew and Sontheimer, 2009 ). The findings reported by the Cherry and Thompson labs in this issue identify Ars2 as a new factor in the RNA silencing machinery that functions in antiviral defense in flies ) and cell proliferation in mammals .
Mammalian cellular proliferation and intrinsic antiviral defense in Drosophila are seemingly unrelated processes, and it therefore comes as a surprise that a single protein factor is at the core of both mechanisms. In mammals, a truncated version of Ars2 has been implicated in arsenic resistance, but the full-length protein regulates cell proliferation through a possible effect on RNA metabolism (Wilson et al., 2008) . Interestingly, the plant homolog of Ars2, SERRATE, is an essential factor in miRNA biogenesis (Grigg et al., 2005) that interacts with the nuclear cap-binding complex (CBC) (Laubinger et al., 2008) and the RNase III enzyme Dicer-Like 1 (DCL1) (Dong et al., 2008) .
In a search for factors mediating viral resistance in Drosophila, the Cherry lab performed a small-scale screen and found that loss of Ars2 results in a 5-fold increase in infectivity for several RNA viruses in both cell culture and adult flies Ars2 directly interacts with Dicer-2 and facilitates the production of siRNAs in the cytoplasm. In addition, Ars2 knockdown impairs miRNA-mediated silencing and reduces pri-miRNA transcript levels, suggesting a role for Ars2 in stabilizing pri-miRNAs. The plant homolog of Ars2, SERRATE, interacts with the CBC (Laubinger et al., 2008) , and conversely a knockout of the CBC components CBP20 and CBP80 in Drosophila results in increased viral infectivity and loss of RNA silencing. Surprisingly, none of the well-known components of the RNA silencing machinery (Dicer-2, Ago2, R2D2) show up as regulators of viral infectivity in the screen; however, this could be explained by the relatively small number of genes tested (about 100). Working in mammalian cells, the Thompson lab investigated the mechanism behind Ars2-mediated cell survival and find that the loss of Ars2 causes severe proliferation defects in conditional knockout mice and in mouse and human cell lines deficient in Ars2. Mass spectrometry analysis shows that Ars2 associates with the CBC component CBP80, but not with its cytoplasmic counterpart eIF4E, and interacts specifically with capped RNAs. This suggests a functional overlap with SERRATE: both Ars2 and the CBC are required for miRNA-mediated silencing, and Ars2 furthermore binds Drosha and stimulates cleavage activity and fidelity for a subset of pri-miRNAs. Importantly, Ars2 expression is low during cell quiescence and high during proliferation, suggesting that correct pri-miRNA processing may be correlated with the proliferative state of the cell.
The authors suggest two nonexclusive models to explain the many roles of Ars2 in RNA silencing in flies and mammals (Figure 1) . In the first model, a complex of CBC and Ars2 recruits the Microprocessor to nascent pri-miRNA transcripts as seen for SERRATE in plants ( Figure 1A) ; pri-miRNA processing has been shown to occur cotranscriptionally, even preceding splicing (Morlando et al., 2008) , and the efficient recruitment of the Micro processor is therefore essential. Ars2 may simultaneously stabilize pri-miRNA transcripts, although the opposite is seen for SERRATE in plants (Laubinger et al., 2008 ). The second model suggests that Ars2 enhances the cleavage activity and possibly the specificity of RNase III enzymes ( Figure 1C ); although this model would explain the widespread function of Ars2 in RNA silencing and is supported by studies in plants, it should be investigated further in a recombinant system, similar to prior investigation of DCL1 and SERRATE (Dong et al., 2008) . Neither of the models explain why only some miRNAs are dependent on Ars2 and the CBC for their expression, but it is tempting to speculate that genomic location (intronic or intergenic transcripts) or RNA secondary structure will determine if accessory processing factors are required.
The exact role of Ars2 and the CBC in antiviral defense in Drosophila warrants further investigation. Given that the CBC is expected to affect processing of mRNAs as well as miRNAs it will be crucial to distinguish between a specific role in battling viral infection and a more general effect on mRNA processing. In plants, SERRATE and the CBC play dual roles in stimulating splicing as well as miRNA processing (Laubinger et al., 2008) , and future studies should address whether Ars2 serves similar functions in both miRNA and mRNA processing in animals ( Figure  1B) . The existence of an RNAi-based antiviral system in vertebrates is controversial, but it would still be interesting to see if knockdown of Ars2 affects viral infectivity in mammalian cells.
The two studies described here shed light on an evolutionarily conserved link between the RNA silencing pathway and mRNA processing but leave several questions open: Is the Microprocessor recruited to all capped, nascent transcripts or does an additional specificity factor distinguish between pri-miRNAs and pre-mRNAs? Can Ars2 directly bind to miRNA precursors as seen for other proteins modulating pri-miRNA process- ing or is it only engaged in protein-protein interactions? Is the increase in Ars2 levels observed during the transition from cell quiescence to proliferation reflected in expression of miRNAs dependent on Ars2 for correct processing? And if so, what sequence or structure motif causes these miRNAs to be responsive to Ars2? Finally, given the small number of genes screened for involvement in viral resistance, how many other regulatory components are still waiting to be identified? With a growing understanding of the mechanisms behind small RNA pathways the new challenge in RNA biology is to understand how the silencing machinery is interconnected with general RNA metabolism. We have certainly not seen the last canonical RNA metabolic factor crossing over into the miRNA field.
The cancer stem cell hypothesis postulates that the progeny of a small pluripotent population of malignant stem cells makes up the bulk of a malignant tumor. Among cancers, acute myeloid leukemia (AML) has the most clearly defined population of stem cells-known as leukemic stem cells (LSCs)-that is responsible for AML persistence and relapse. Therefore, there is considerable interest in identifying therapies that specifically target this particular population of cells. Leukemic stem cells and their normal counterpart, the hematopoietic stem cells (HSCs), show remarkable resilience to the direct cytotoxic and indirect inflammatory effects of chemotherapy. This results, in part, from their ability to circulate freely in the peripheral blood and repopulate the bone marrow stem cell niche while avoiding phagocytosis by activated macrophages (Figure 1 ). In this issue of Cell, Jaiswal et al. (2009) and Majeti et al. (2009) show that the immunoglobulin-like protein CD47 expressed by LSCs acts as an inhibitor of macrophage activity and directly promotes enhanced survival and engraftment of LSCs (Figure 1) . Furthermore, they demonstrate that high levels of CD47 on LSCs isolated from patients with AML are predictive of leukemia resistance to therapy, possibly reflecting the ability of LSCs to avoid macrophagemediated control.
CD47 is a membrane protein that functions in neutrophil trafficking, T cell costimulation, and neuronal regeneration (Matozaki et al., 2009) . CD47 also interacts with a specific macrophage receptor, SIRPα, to downregulate the phagocytic potential of macrophages (van den Berg and van der Schoot, 2008) . Given that mobilized HSCs in the blood stream come into contact with macrophages of the reticulo-endothelial
